GRITSTONE ONCOLOGY INC's ticker is GRTS and the CUSIP is 39868T105. A total of 73 filers reported holding GRITSTONE ONCOLOGY INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $61,235 | -11.8% | 35,602 | 0.0% | 0.00% | – |
| Q2 2023 | $69,424 | +5.2% | 35,602 | +123.6% | 0.00% | – |
| Q1 2022 | $66,000 | -67.8% | 15,920 | 0.0% | 0.00% | – |
| Q4 2021 | $205,000 | +16.5% | 15,920 | -2.2% | 0.00% | – |
| Q3 2021 | $176,000 | +18.1% | 16,274 | 0.0% | 0.00% | – |
| Q2 2021 | $149,000 | +12.9% | 16,274 | +16.5% | 0.00% | – |
| Q1 2021 | $132,000 | +116.4% | 13,975 | -9.8% | 0.00% | – |
| Q4 2020 | $61,000 | +117.9% | 15,488 | +47.6% | 0.00% | – |
| Q3 2020 | $28,000 | -60.0% | 10,495 | 0.0% | 0.00% | – |
| Q2 2020 | $70,000 | -2.8% | 10,495 | -15.0% | 0.00% | – |
| Q1 2020 | $72,000 | -35.1% | 12,342 | 0.0% | 0.00% | – |
| Q4 2019 | $111,000 | – | 12,342 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 3,561,150 | $6,125,178 | 3.26% |
| Redmile Group, LLC | 8,509,126 | $14,635,697 | 0.70% |
| Avidity Partners Management LP | 2,733,800 | $4,702,136 | 0.19% |
| Frazier Life Sciences Management, L.P. | 1,430,878 | $2,461,110 | 0.16% |
| Artia Global Partners LP | 95,170 | $163,692 | 0.07% |
| Worth Venture Partners, LLC | 43,772 | $75,288 | 0.04% |
| SkyOak Wealth, LLC | 60,875 | $104,705 | 0.03% |
| Point72 Asset Management, L.P. | 5,924,867 | $10,190,771 | 0.03% |
| CORNERCAP INVESTMENT COUNSEL INC | 76,811 | $132,115 | 0.02% |
| Houlihan Financial Resource Group, Ltd. | 20,000 | $38 | 0.02% |